| ALMIRALL S.A. EO -,12 | 10.940 / +1.02% |
| Date/Time | 11/27 / 08:06 |
| Chg. / Chg.(%) | 0.110 / +1.02% |
| Bid | - |
| Ask | - |
| Open | 10.940 |
| Previous Close | 10.830 |
| High | 10.940 |
| Low | 10.940 |
| Volume [EUR] | 0.000 |
| Volume [Units] | 0 |
| Price fixings | 1 |
| ISIN | ES0157097017 |
| Security | E2Z |
| Exchange | Berlin |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 10.860 |  |
|
| Madrid | 10.9800 | |
373,171 |
| Cboe Europe .. | 10.97 | |
42,202 |
| London Inter.. | 11.04 | |
34,766 |
| Cboe Europe .. | 10.96 | |
17,580 |
| Turquoise | 10.96 | |
2,164 |
| TradeGate | 11.00 |  |
205 |
| Frankfurt | 10.9400 | |
0 |
| Berlin | 10.940 | |
0 |
| Stuttgart | 10.860 | |
0 |
| Nasdaq Other.. | 12.4000 | 1,087 |
News
- Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference
11/12/2020 / 22:01 - GlobeNewswire - Sientra Appoints Ron Menezes as President and Chief Executive Officer
11/09/2020 / 22:01 - GlobeNewswire - Paratek Pharmaceuticals Announces Third Quarter 2020 Total Revenue of $13.7 Million
11/05/2020 / 22:01 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11/02/2020 / 22:05 - GlobeNewswire - Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020
10/27/2020 / 13:00 - GlobeNewswire
Real-time